WEINER DAVID B has a total of 67 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1994. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are RESPONSIF GMBH, ENGENEIC MOLECULAR DELIVERY PTY LTD and LIGOCYTE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 44 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 3 | |
#4 | South Africa | 3 | |
#5 | Australia | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Israel | 2 | |
#8 | Mexico | 2 | |
#9 | China | 1 | |
#10 | Republic of Korea | 1 | |
#11 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Medical technology | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials | |
#7 | Sugars | |
#8 | Electrotherapy | |
#9 | Syringes | |
#10 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Weiner David B | 60 |
#2 | Yan Jian | 21 |
#3 | Muthumani Karuppiah | 15 |
#4 | Patel Ami | 9 |
#5 | Elliott Sarah | 8 |
#6 | Kutzler Michele | 8 |
#7 | Wang Bin | 8 |
#8 | Williams William V | 7 |
#9 | Flingai Seleeke | 7 |
#10 | Coney Leslie R | 6 |
Publication | Filing date | Title |
---|---|---|
WO2018102657A1 | Dna antibody constructs for use against ebola virus | |
CN109890407A | DNA antibody construct and its application method | |
US2012093863A1 | HCV vaccines and methods for using the same | |
US2012053509A1 | Vaccines for human papilloma virus and methods for using the same | |
US2013273112A1 | Consensus antigen constructs and vaccines made therefrom, and methods of using the same to treat malaria | |
US2013017224A1 | Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same | |
US2011182938A1 | Influenza nucleic acid molecules and vaccines made therefrom | |
US2011184160A1 | Nucleic acid molecule encoding consensus influenza a hemagglutinin h1 | |
US2010189730A1 | Vaccines for human papilloma virus and methods for using the same | |
US2012034256A1 | HCV vaccines and methods for using the same | |
US2008274140A1 | Vaccines and Methods for Using the Same | |
US2008219953A1 | Cosmid DNA constructs and methods of making and using same | |
IL108707D0 | Pharmaceutical compositions and diagnostic kits comprising hiv protein vpr or proteins that bind to vpr | |
ZA9400493B | Compositions and methods for delivery of genetic material |